Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure

被引:13
|
作者
Bernocchi, P
Cargnoni, A
Vescovo, G
Dalla Libera, L
Parrinello, G
Boraso, A
Ceconi, C
Ferrari, R
机构
[1] Fdn Salvatore Maugeri, Cardiovasc Res Ctr, IRCCS, I-25064 Gussago, Brescia, Italy
[2] Hosp Adria, Dept Internal Med, Rovigo, Italy
[3] Univ Padua, CNR, Unit Muscle Physiopathol, I-35100 Padua, Italy
[4] Univ Brescia, Dept Stat, I-25121 Brescia, Italy
[5] Univ Brescia, Chair Cardiol, I-25121 Brescia, Italy
[6] Hosp Brescia, Chair Cardiol, Brescia, Italy
[7] Univ Ferrara, Chair Cardiol, I-44100 Ferrara, Italy
关键词
heart failure; oxidative capacity; skinned muscle fibres; O-2; consumption;
D O I
10.1007/s003950300001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In congestive heart failure (CHF), function and metabolism of skeletal muscles are abnormal. Aim To evaluate whether the reduced oxidative capacity of skeletal muscles in CHF is due to impaired 0, utilisation. Methods CHF was induced in rats by injecting 50 mg/Kg monocrotaline. Several animals received the same dose of monocrotaline but only compensated right ventricular hypertrophy and no sign of congestion resulted. Two age- and diet-matched groups of control animals were also studied. in soleus and extensor digitorum longus (EDL) muscles, we studied skeletal muscle blood flow, oxidative capacity and respiratory function of skinned muscle fibres. Results In CHF, we observed a decrease of muscle blood flow (statistically significant in the soleus, p < 0.05 vs. controls). In compensated rats, a similar trend in blood flow was observed. in both soleus and EDL, a significant reduction of high energy phosphate and a shift of the redox potential towards accumulation of reducing equivalents were observed. The reduction of energy charge was not correlated to the decrease of blood flow. In skinned myofibres, the ratio of 0, utilised in the presence and in absence of ADP (an index of phoshorilating efficiency) was reduced from 8.9 +/- 1.9 to 2.7 +/- 0.2 (p < 0.001) and from 5.7 +/- 1.0 to 2.0 +/- 0.3 (p < 0.01) in soleus and EDL, respectively. Activity of the different complexes of respiratory chain was investigated by means of specific inhibitors, showing major abnormalities at the level of complex I. In fact, inhibition of VO2 by rotenone was decreased from 83.5 +/- 3.2 to 36.4 +/- 9.6 % (p < 0.005) and from 81.8 +/- 6.1 to 38.2 +/- 7.4 % (p < 0.005) in soleus and EDL, respectively. Conclusions In rats with CHF, abnormalities of oxidative phosphorylation of muscles occur and complex I of the respiratory chain seem to be primarily affected. The metabolic alterations of skeletal muscles in CHF may be explained, at least in part, by an impaired O-2 utilisation.
引用
收藏
页码:114 / 123
页数:10
相关论文
共 50 条
  • [21] Skeletal muscle bioenergetics in aging and heart failure
    Sophia Z. Liu
    David J. Marcinek
    Heart Failure Reviews, 2017, 22 : 167 - 178
  • [22] Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy
    Vescovo, G
    Ceconi, C
    Bernocchi, P
    Ferrari, R
    Carraro, U
    Ambrosio, GB
    Dalla Libera, L
    CARDIOVASCULAR RESEARCH, 1998, 39 (01) : 233 - 241
  • [23] Heart failure: a model of cardiac and skeletal muscle energetic failure
    B. Mettauer
    J. Zoll
    A. Garnier
    R. Ventura-Clapier
    Pflügers Archiv, 2006, 452 : 653 - 666
  • [24] Heart failure: a model of cardiac and skeletal muscle energetic failure
    Mettauer, B.
    Zoll, J.
    Garnier, A.
    Ventura-Clapier, R.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2006, 452 (06): : 653 - 666
  • [25] Dynamics of microvascular oxygen partial pressure in contracting skeletal muscle of rats with chronic heart failure
    Diederich, ER
    Behnke, BJ
    McDonough, P
    Kindig, CA
    Barstow, TJ
    Poole, DC
    Musch, TI
    CARDIOVASCULAR RESEARCH, 2002, 56 (03) : 479 - 486
  • [26] B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure
    Larsen, Alf Inge
    Skadberg, Oyvind
    Aarsland, Torbjorn
    Kvaloy, Jan Terje
    Lindal, Sigurd
    Omland, Torbjorn
    Dickstein, Kenneth
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 136 (03) : 358 - 362
  • [27] Metabolic and structural impairment of skeletal muscle in heart failure
    Zizola, Cynthia
    Schulze, P. Christian
    HEART FAILURE REVIEWS, 2013, 18 (05) : 623 - 630
  • [28] Effect of thalidomide on the skeletal muscle in experimental heart failure
    Vescovo, G
    Ravara, B
    Angelini, A
    Sandri, M
    Carraro, U
    Ceconi, C
    Libera, LD
    EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (04) : 455 - 460
  • [29] Exercise training in heart failure patients: effects on skeletal muscle abnormalities and sympathetic nervous activity—a literature review
    Iliopoulos F.
    Mazis N.
    Sport Sciences for Health, 2018, 14 (2) : 217 - 226
  • [30] Metabolic and structural impairment of skeletal muscle in heart failure
    Cynthia Zizola
    P. Christian Schulze
    Heart Failure Reviews, 2013, 18 : 623 - 630